Specifically, miRNA-375 targets directly PDK1 and miRNA-200c targets MUC4 (Mucin 4), influencing epithelial–mesenchymal transition and metastatic potential in pancreatic cancer cells [53,54]. Here, MUC4 is linked to familial pancreatic carcinoma.